{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T11:30:44Z","timestamp":1744198244271},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.coph.2008.12.008","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T20:32:02Z","timestamp":1232569922000},"page":"132-138","source":"Crossref","is-referenced-by-count":6,"title":["Possible new druggable targets for the treatment of nephrosis"],"prefix":"10.1016","volume":"9","author":[{"given":"Richard PE","family":"van Dokkum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Buikema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2008.12.008_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1440-1797.2007.00890.x","article-title":"Adult nephrotic syndrome: non-specific strategies for treatment","volume":"3","author":"Charlesworth","year":"2008","journal-title":"Nephrology"},{"key":"10.1016\/j.coph.2008.12.008_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000407066","article-title":"Glomerular response to renal injury","volume":"33","author":"Brenner","year":"1982","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.coph.2008.12.008_bib3","first-page":"122","article-title":"The hemodynamic basis of progressive renal disease","volume":"6","author":"Dunn","year":"1986","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.coph.2008.12.008_bib4","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM199811123392007","article-title":"Pathophysiology of progressive nephropathies","volume":"339","author":"Remuzzi","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2008.12.008_bib5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/ndt\/14.2.304","article-title":"Nephrotoxicity of increased glomerular protein traffic","volume":"14","author":"Abbate","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.coph.2008.12.008_bib6","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00467-007-0524-0","article-title":"Mechanisms of progression of chronic kidney disease","volume":"22","author":"Fogo","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.coph.2008.12.008_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11154-008-9100-6","article-title":"New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy","volume":"9","author":"Brosius","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.coph.2008.12.008_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00285287","article-title":"Albuminuria reflects widespread vascular damage. The Steno hypothesis","volume":"32","author":"Deckert","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/j.coph.2008.12.008_bib9","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1681\/ASN.2006030204","article-title":"Cross-talk between the kidney and the cardiovascular system","volume":"17","author":"Amann","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.coph.2008.12.008_bib10","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1681\/ASN.2005121288","article-title":"Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms","volume":"17","author":"Stehouwer","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.coph.2008.12.008_bib11","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1681\/ASN.2006050517","article-title":"Microalbuminuria as an early marker for cardiovascular disease","volume":"17","author":"de Zeeuw","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.coph.2008.12.008_bib12","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1046\/j.1523-1755.2000.07505.x","article-title":"Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases","volume":"75","author":"Fogo","year":"2000","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.coph.2008.12.008_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.semnephrol.2005.05.016","article-title":"Treatment of hypertension in chronic kidney disease","volume":"25","author":"Toto","year":"2005","journal-title":"Semin Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.coph.2008.12.008_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003495-200565002-00005","article-title":"Renal protection in hypertensive patients: selection of antihypertensive therapy","volume":"65","author":"Wenzel","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.coph.2008.12.008_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0828-282X(07)70808-5","article-title":"Canadian Hypertension Education Program. Treatment of hypertension in patients with nondiabetic chronic kidney disease","volume":"23","author":"Ruzicka","year":"2007","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.coph.2008.12.008_bib16","first-page":"23","article-title":"Angiotensin II induces hypertrophy and hyperplasia in adult human mesangial cells","volume":"3","author":"Orth","year":"1995","journal-title":"Exp Nephrol"},{"key":"10.1016\/j.coph.2008.12.008_bib17","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1681\/ASN.V391531","article-title":"Angiotensin II as a renal growth factor?","volume":"3","author":"Wolf","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.coph.2008.12.008_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ki.1997.20","article-title":"Modulation of plasminogen activator inhibitor-1 (PAI-1) in vivo: a new mechanism for the anti-fibrotic effect of renin\u2013angiotensin inhibition","volume":"51","author":"Oikawa","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.coph.2008.12.008_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.ph.57.030195.001431","article-title":"Transforming growth factor-b and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?","volume":"57","author":"Ketteler","year":"1995","journal-title":"Ann Rev Physiol"},{"key":"10.1016\/j.coph.2008.12.008_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MNH.0b013e32831c50a1","article-title":"Mechanisms of kidney fibrosis and the role of anti-fibrotic therapy","volume":"18","author":"Deelman","year":"2009","journal-title":"Cur Op Nephrol Hypertens"},{"key":"10.1016\/j.coph.2008.12.008_bib21_1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5000054","article-title":"Renal fibrosis: new insights into the pathogenesis and therapeutics","volume":"69","author":"Liu-Y.","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.coph.2008.12.008_bib22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00467-008-0789-y","article-title":"Therapeutic strategies to slow chronic kidney disease progression","volume":"23","author":"W\u00fchl","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.coph.2008.12.008_bib23_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/187153007780832118","article-title":"Novel therapeutic targets for diabetic nephropathy","volume":"7","author":"Fukami","year":"2007","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.coph.2008.12.008_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biopha.2004.06.003","article-title":"Renal glomerular permselectivity and vascular endothelium","volume":"59","author":"Camici","year":"2005","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.coph.2008.12.008_bib25","first-page":"586","article-title":"Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population wit mild renal insufficiency: the Hoorn study","volume":"61","author":"Stam","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 12","key":"10.1016\/j.coph.2008.12.008_bib26","first-page":"S39","article-title":"The endothelium as a target in renal diseases","volume":"20","author":"Zoccali","year":"2007","journal-title":"J Nephrol"},{"key":"10.1016\/j.coph.2008.12.008_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease. Effects of the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2008.12.008_bib28","first-page":"970","article-title":"Endothelial dysfunction and chronic kidney disease: treatment options","volume":"9","author":"Wu-Wong","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.coph.2008.12.008_bib29","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1126\/science.1062688","article-title":"Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice","volume":"293","author":"Drab","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.coph.2008.12.008_bib30","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.lfs.2007.01.041","article-title":"Disruption of endothelial caveolae is associated with impairment of both NO- as well as EDHF in acetylcholine-induced relaxation depending on their relative contribution in different vascular beds","volume":"80","author":"Xu","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.coph.2008.12.008_bib31","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.ATV.0000070546.16946.3A","article-title":"Caveolin, caveolae, and endothelial cell function","volume":"23","author":"Frank","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.coph.2008.12.008_bib32","doi-asserted-by":"crossref","first-page":"26323","DOI":"10.1074\/jbc.273.41.26323","article-title":"Rapid mechanotransduction in situ at the luminal cell surface of the microvascular endothelium and its caveolae","volume":"273","author":"Rizzo","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2008.12.008_bib33","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cellsig.2007.01.004","article-title":"Mechanical stress-initiated signal transduction in vascular smooth muscle cells in vitro and in vivo","volume":"19","author":"Li","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.coph.2008.12.008_bib34_1","doi-asserted-by":"crossref","unstructured":"Xu Y, Henning RH, Sandovici M, van der Want JJL, van Gilst WH, Buikema H: Enhanced myogenic constriction of mesenteric artery in heart failure relates to decreased smooth muscle cell caveolae number and altered AT1-receptor and EGF-receptor function. Eur J Heart Fail 2009, in press.","DOI":"10.1093\/eurjhf\/hfn027"},{"key":"10.1016\/j.coph.2008.12.008_bib35","doi-asserted-by":"crossref","first-page":"R1222","DOI":"10.1152\/ajpregu.00092.2007","article-title":"Arterial remodeling and plasma volume expansion in caveolin-1-deficient mice","volume":"293","author":"Albinsson","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.coph.2008.12.008_bib36_1","doi-asserted-by":"crossref","first-page":"H1584","DOI":"10.1152\/ajpheart.00584.2006","article-title":"Caveolin-1 abolishment attenuates the myogenic response in murine cerebral arteries","volume":"292","author":"Adebiyi","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.coph.2008.12.008_bib37","doi-asserted-by":"crossref","first-page":"R855","DOI":"10.1152\/ajpregu.1999.276.3.R855","article-title":"Altered renal hemodynamics and impaired myogenic responses in the fawn-hooded rat","volume":"276","author":"Van Dokkum","year":"1999","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.coph.2008.12.008_bib38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejphar.2008.02.086","article-title":"Caveolae and endothelial dysfunction: filling the caves in cardiovascular disease","volume":"585","author":"Xu","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2008.12.008_bib39","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s004670000534","article-title":"Control of glomerular capillary development by growth factors\/receptor kinases","volume":"16","author":"Robert","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.coph.2008.12.008_bib40","first-page":"12605","article-title":"Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFit-1) induces proteinuria","volume":"278","author":"Sugimoto","year":"2003","journal-title":"J Biochem"},{"key":"10.1016\/j.coph.2008.12.008_bib41","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/01.ASN.0000115397.22519.03","article-title":"Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties","volume":"15","author":"Satchell","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.coph.2008.12.008_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/1874091X00701010012","article-title":"Lipid rafts and caveolae in signaling by growth factor receptors","volume":"1","author":"De Laurentiis","year":"2007","journal-title":"Open Biochem J"},{"key":"10.1016\/j.coph.2008.12.008_bib43_1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1089\/ars.2007.1556","article-title":"VEGF signaling through NADPH oxidase-derived ROS","volume":"9","author":"Ushio-Fukai","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.coph.2008.12.008_bib44","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1158\/0008-5472.CAN-06-4082","article-title":"Caveolin-1 deficient mice have increased tumor microvascular permeability, angiogenesis, and growth","volume":"67","author":"Lin","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.coph.2008.12.008_bib45","doi-asserted-by":"crossref","first-page":"C1053","DOI":"10.1152\/ajpcell.00292.2001","article-title":"VEGF-induced mobilization of caveolae and increase in permeability of endothelial cells","volume":"282","author":"Chen","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.coph.2008.12.008_bib46","article-title":"Compartmentalization of Redox Signalling through NADPH Oxidase-derived ROS","author":"Ushio-Fukai","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.coph.2008.12.008_bib47_1","doi-asserted-by":"crossref","first-page":"F153","DOI":"10.1152\/ajprenal.00419.2007","article-title":"TGF\u03b2-induced RhoA activation and fibronectin production in mesangial cells require caveolae","volume":"295","author":"Peng","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.coph.2008.12.008_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00441-008-0659-8","article-title":"Caveolae and transcytosis in endothelial cells: role in atherosclerosis","volume":"335","author":"Frank","year":"2009","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.coph.2008.12.008_bib49","doi-asserted-by":"crossref","first-page":"40091","DOI":"10.1074\/jbc.M205948200","article-title":"Microvascular hyperpermeability in caveolin-1 (\u2212\/\u2212) knockout mice: treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice","volume":"277","author":"Schubert","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2008.12.008_bib50","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/0002-9149(92)90710-G","article-title":"Endothelial dysfunction in chronic congestive heart failure","volume":"69","author":"Drexler","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.coph.2008.12.008_bib51","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00377.2001","article-title":"Relationships between caveolae and eNOS: everything in proximity and the proximity of everything","volume":"52","author":"Goligorsky","year":"2002","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489208002087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489208002087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T08:51:21Z","timestamp":1632991881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489208002087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1471489208002087"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2008.12.008","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}